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ABSTRACT
Most type II restriction-modification (R-M) systems
produce separate endonuclease (REase) and
methyltransferase (MTase) proteins. After R-M
genes enter a new cell, MTase activity must
appear before REase or the host chromosome will
be cleaved. Temporal control of these genes thus
has life-or-death consequences. PvuII and some
other R-M systems delay endonuclease expression
by cotranscribing the REase gene with the upstream
gene for an autogenous activator/repressor (C pro-
tein). C.PvuII was previously shown to have low
levels early, but positive feedback later boosts tran-
scription of the C and REase genes. The MTase is
expressed without delay, and protects the host
DNA. C.PvuII binds to two sites upstream of its
gene: OL, associated with activation, and OR, asso-
ciated with repression. Even when symmetry ele-
ments of each operator are made identical, C.PvuII
binds preferentially to OL. In this study, the intra-
operator spacers are shown to modulate relative
C.PvuII affinity. In light of a recently reported
C.Esp1396I-DNA co-crystal structure, in vitro and
in vivo effects of altering OL and OR spacers were
determined. The results suggest that the
GACTnnnAGTC consensus is the primary determi-
nant of C.PvuII binding affinity, with intra-operator
spacers playing a fine-tuning role that affects mobil-
ity of this R-M system.
INTRODUCTION
Many bacteria and archaea possess restriction-
modiﬁcation (R-M) systems (1), at least in part for defense
against DNA bacteriophages. PvuII, like other type II
R-M systems (2), includes two separate enzymes: a restric-
tion endonuclease (REase) that cleaves DNA at a tar-
get sequence, and a methyltransferase (MTase) that
modiﬁes the same sequence to protect it from the cognate
REase (3–8).
The PvuII R-M system is naturally carried on a plasmid
together with mobilization genes (9,10). If the system is to
be mobile, the REase and MTase activities must be care-
fully balanced in a relatively host-independent manner, so
as to minimize killing of new host cells that initially have
completely unmethylated chromosomes. Any R-M system
misregulation would lead to auto-restriction and cell death
if REase activity is too high (11,12), or would weaken
defense against bacteriophage invasion if MTase activity
is too high (13). In addition to the evident eﬀects of R-M
systems on resistance to bacteriophages (14), the roles of
restriction in modulating gene ﬂow between bacteria
are also clear (15–19). The regulation of R-M systems
having only REase and MTase genes is under active inves-
tigation (20,21).
A subset of type II R-M systems contains regulatory
genes in addition to the MTase and REase genes. The
regulatory C (controlling) gene was ﬁrst discovered in
the PvuII (22) and BamHI (23) R-M systems. Subse-
quently, active regulatory genes have been demonstrated
in several other systems (24). The C proteins are quite
small [PvuII has a subunit MW of 9.4kDa (25)] and
appear to have a remarkably broad host range for their
action (26,27).
C proteins, where tested, activate and repress their own
transcription autogenously (28,29). In the PvuII R-M
system at least (Figure 1A and B), the C protein is respon-
sible for delayed REase appearance after entering a new
host cell (30); this gives the MTase time to protect the new
host’s genome. In R-M systems having a C gene, the
REase gene typically does not have its own promoter
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C and REase open reading frames usually overlap, and the
REase gene is completely dependent on transcription
from the upstream autogenously regulated C gene (33).
Disruption of pvuIIC leads to a drastic reduction in
REase expression, that can be restored by supplying the
C gene in trans (22,34). In a new host cell REase expres-
sion is low until C protein accumulates (30). This is
consistent with the observation that pre-expressing C
protein prevents transformation by the intact cognate
R-M system, presumably due to premature REase expres-
sion and cleavage of recipient cells’ chromosomal
DNA (27,33).
The C proteins act on conserved operator sequences
called ‘C boxes’ (33,35,36). Functional C boxes have
been determined for C.PvuII (33) and several other C
proteins (24,29,37,38). We have previously explored the
roles of the GACTnnnAGTC symmetry elements and
the inter-operator TGTA spacer (28). We found that
any substitution within the TGTA eliminated transcrip-
tion activation by C.PvuII, and noted that the PvuII-
related C-boxes fall into two classes based on this spacer
(TGTA versus CGTA), with co-variation of the cognate C
protein predicted recognition helices (HRTY versus
DRTY) (28).
The palindromic nature of C boxes suggests that each of
the two C boxes (designated as 1AB or OL, operator left,
and 2AB or OR, operator right; Figure 1B) could each be
bound by the helix–turn–helix motifs of a C protein
homodimer (39). The two operators have conserved
center-to-center spacing of 15bp (Figure 1C), meaning
that the two C homodimers occupy opposite faces of the
DNA double helix (25,33,40).
Recently, a C protein–DNA operator co-crystal struc-
ture was solved for C.Esp1396I (41). As expected, the two
C protein dimers interact with C-box DNA on opposite
faces of the DNA. Surprisingly, a second symmetry pat-
tern (41) (yellow in Figure 2A) was identiﬁed in addition
to the one previously described (33) (blue in Figure 2A).
The center of symmetry is shifted by 0.5nt between the
two patterns. The C.Esp1396I protein DNA co-crystal
structure suggests that the second symmetry pattern is
indeed recognized (41). However, the relative roles of the
two symmetries are not yet clear.
C.PvuII binding to OL activates transcription, while its
binding to OR represses (28). However C protein binding
to OL and OR is highly cooperative, with a Hill coeﬃcient
of about 4 (28). Further, when the GACTnnnAGCT
symmetry elements of OL and OR are made identical,
activation still occurs (28). This alone might be explained
by a proposed in vivo competition at OR between C.PvuII
and RpoD (s
70) (42). However, we also ﬁnd a C.PvuII
binding preference for OL over OR in vitro, even with
identical symmetry elements and in the absence of RpoD
(28). This result suggests a key role for the two asymmet-
rical intra-operator spacer sequences (boxes in Figure 1C).
In this paper we focus on the role of these spacers,
their contribution to C protein aﬃnity for the two
operators and the resulting impact on R-M system
establishment.
A
B
C
Figure 1. PvuII R-M system control region. (A) Genetic structure. The three genes specify a DNA methyltransferase (pvuIIM), restriction endonu-
clease (pvuIIR) and controller (activator/repressor, pvuIIC). The two transcription starts for pvuIICR are identiﬁed by rightward bent arrows: from
the C-independent weak promoter (thin) and C-dependent strong promoter (thick) (25). The two pvuIIM promoters are also shown (leftward bent
arrows). The four vertical rectangles represent the C-boxes, which are binding sites for C.PvuII. (B) The pvuIICR regulatory region sequence showing
C-boxes and promoter elements. The nearly palindromic operators each contain a pair of C-boxes, designated as boxes 1AB or OL (operator left) and
2AB or OR (operator right). Conserved elements of the stronger, C-dependent promoter are indicated by heavy rectangles, while thinner rectangles
indicate the weak C-independent promoter. Transcript starts are indicated by bent arrows. (C) C-box sequence Logos. The Logos represent the
subset of C-box regions associated with the subset of C proteins having HRTY in the recognition helix [21 cases, (28)]. The Logo (55) was generated
by the server at http://weblogo.berkeley.edu. The C-box intra-operator spacers are boxed, and the central TGTA inter-operator spacer is underlined.
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Strains, phages andplasmids
The Escherichia coli K-12 strains used in this study are
described below. All strains into which pvuIIM is intro-
duced must lack the mcrBC restriction system (9,43,44).
MC1061 [araD139 (ara, leu)7697, lacX74, galU,
galK, hsdR, strA] (45) is able to transport arabinose but
is deﬁcient in its metabolism; it was used as the host
for in vivo titrations with C.PvuII. TOP10 (Invitrogen;
mcrA mrr-hsdRMS-mcrBC f80lacZM15 lacX74
recA1 araD139 (ara-leu)7697 galU galK rpsL(Str
R)
endA1 nupG’) was used for all other purposes including
cloning steps and CAT assay. [Top10 with F0(lacI
q,
Tn10(Tet
R)] was used as the host strain for M13 phage
infections. The plasmids used are listed in Table S1.
Recombinant phage M13pvuIIwt were handled as
described before (30).
Invivo titration of C.PvuII and M.PvuII
PCR-ampliﬁed genes for C.PvuII or M.PvuII were cloned
downstream of the arabinose-inducible PBAD promoter in
vector pBAD24 (46) yielding plasmids pIM1 (28) and
pBadMTwt, respectively. Arabinose induction yielded
CAT/CAA - PvuSym
C.PvuII (0-500nM)
TAT/TAT
TAT/CGC
CGC/TAT
CGC/CGC
B
0
1
2
0
1
2
0
1
2
0
1
2
0
1
2
A
0
500
1000
1500
2000
10-6
10−5 0.0001 0.001 0.01 0.1 1
CAT/CAA WT SYM
CGC/CGC
TAT/TAT
no C-box
L
a
c
Z
 
s
p
e
c
i
f
i
c
 
a
c
t
i
v
i
t
y
 
(
m
o
d
.
 
M
i
l
l
e
r
 
u
n
i
t
s
)
Ara conc (%)
C
0
 OL OR 1A           1B        2A           2B
+
Figure 2. Testing the two alternative symmetry patterns in the C-box region. (A) Two alternative symmetry patterns. The top portion shows the
‘AGTC’ consensus [in blue, (33)] comprising the C-box elements themselves, the actual sequence from PvuII R-M system, and the ‘TATA’ consensus
[in yellow, (41)]. The centers of symmetry are shown. The numbers at the right indicate the extent of match to each consensus, and whether a
characteristic repression complex forms in vitro at  500nM C.PvuII. The lower portion shows several previously tested C.PvuII operator variants
(28). Magenta shading indicates mutations introduced in each case, in the context of symmetrized C-boxes (underlined positions). (B) Binding eﬀects
of ‘TATA’ consensus alteration. A series of 126-bp dsDNA-binding targets were prepared by PCR ampliﬁcation, and included in each binding
reaction at 20nM. The DNAs contained WT or variant C boxes ﬂanked on either side by 50bp of native PvuII sequence. EMSA reactions with
concentrations of C.PvuII increasing from 0–500nM were processed as outlined in ‘Materials and methods’ section. PvuSym indicates wild-type
spacers in the context of symmetrized C-box sequences (see sequence in A). Other variants are in the same sequence context, but with diﬀerent intra-
operator spacers as indicated (OL/OR). Reactions were resolved on 10% native polyacrylamide gels, and DNA was visualized by staining with
ethidium bromide. Numbers at right indicate the expected numbers of bound C.PvuII dimers. (C) In vivo titration of intra-operator spacers variants
with C.PvuII. Cells, carrying pvuIIC under the control of PBAD, were grown in minimal media with 0.2% glucose and the indicated concentration of
arabinose, as described before (28). Expression from variants (labeled as in B) was measured via transcriptional fusion of the variant C-boxes/
PpvuIICR to reporter gene lacZ. Each point represents b-galactosidase speciﬁc activity, determined by linear regression of the plot of LacZ activity
(modiﬁed Miller units) versus optical density of the culture, as previously (49). Each point represents the slope of a regression from at least 3 points;
in all cases R
2 was >0.97. The beginning of the curve (0), indicates values obtained in glucose with no arabinose. Black diamonds represent LacZ
activity from cells with the WT symmetrized PvuII C-boxes with CAT/CAA intra-operator spacers (pIM8). The ‘TATA’ consensus variant (TAT/
TAT) is shown as blue circles, and the ‘TATA’-disrupted variant (CGC/CGC) is shown as red diamonds. As negative control vector plasmid with no
pvuIIC was used (open circles).
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logical wild-type level (46). Experiments were performed
in MOPS-minimal medium (Teknova) with 0.2% glucose
as carbon source (47) as described before (28). Brieﬂy,
single colonies were used to inoculate overnight cultures
in MOPS media and appropriate antibiotics. These
cultures were diluted 1:50 into the same medium but with-
out antibiotics, and grown with shaking to an OD600nm of
0.2–0.3. The cells were then gently pelleted, resuspended
and divided among ﬂasks containing MOPS-minimal
media with varied concentrations of L-arabinose.
b-Galactosidase assay
TheLacZassayswerebasedonhydrolysisofo-nitrophenyl-
b-D-thiogalactoside (48) as described (49). Brieﬂy,
b-galactosidase activity and culture density were mea-
sured at 20–30-min intervals during exponential growth.
The units for this assay were calculated by dividing the
measured A420nm (released nitrophenol) by the time
allowed for the reaction and by the volume of permea-
bilized cells used for the reaction. The units of b-galac-
tosidase activity are: 1000 iA420nm min
–1ml
–1. The
speciﬁc activity was obtained by determining the slope
of a plot of b-galactosidase activity versus the culture
OD600nm density via linear regression.
Electrophoretic mobility shift assays
DNA substrates were 50-biotinylated, 126-bp double-
stranded PCR-ampliﬁed fragments that included the
entire PpvuIICR region (WT or mutant as indicated).
C.PvuII protein was puriﬁed as described before (28).
Reactions containing 20nM DNA and the indicated pro-
tein concentrations were prepared in binding buﬀer
[50mM Tris–HCl (pH 8.0), 1mM DTT, 10mM MgCl2,
2.5% glycerol] in a ﬁnal volume of 20ml, and incubated for
20min at 228C. Samples were electrophoresed on 10%
native polyacrylamide gels in 0.5  TBE buﬀer for
90min at 100V at 228C. The location of dsDNA in the
gels was determined either via ethidium bromide staining
and photography with UV transillumination, or DNA was
transferred by electroblotting to positively charged
nylon membranes (Ambion), and the transferred DNA
fragments were immobilized onto the membrane by ultra-
violet cross-linking (50). Detection of the biotin end-
labeled DNA was performed using the North2South
Chemiluminescent Hybridization and Detection Kit
(Pierce) as recommended, and the CCD camera of the
Omega Molecular Imaging System (UltraLum). For com-
petition experiments, the unlabeled variant DNAs were
used at 1-, 2.5-, 5- or 10-fold molar excess over biotin-
labeled WT template followed by addition of C protein,
electrophoresis and analysis as described above.
DNA bending assay
To assess the bending angle of DNA with the C-boxes/
promoter region, we used pBend2 vector (51) that con-
tains two identical sequence fragments with 17 restriction
sites in repeat on either site of XbaI and SalI cloning
sites. The designed pair of 35-nt oligonucleotides with
the wild-type central C-box sequences (CTAGATGC
TACTCATAGTCTGTAGATTCAAAGTCATCG; TC
GACGATGACTTTGAATCTACAGACTATGAGTAG
CAT) were annealed by boiling and cooling to room tem-
perature. These short ds DNA fragments had overhangs
compatible with XbaI and SalI cloning, and were ligated
to XbaI–SalI linearized pBend2 vector. The symmetrical
variant with OL=CAA and OR=CAA was created in
the same way. All constructs were sequence conﬁrmed.
Digestion with various restriction enzymes resulted in
150-bp fragments but with diﬀerent C-box locations.
Individual fragments were puriﬁed by gel extraction and
the concentration was adjusted to obtain the same amount
of DNA. Then, electrophoretic mobility shift assays
(EMSA) was performed as described above using 60nM
of DNA fragment and 200nM of C.PvuII per reaction.
This gives complete occupancy of OL and OR by C.PvuII
(28). Calculation of the average DNA bend angle was
done by ﬁtting relative mobilities to the quadratic function
y=ax
2 – bx+c, where a=–b=2c(1 cosa) and a is the
bend angle to be determined (52).
Western blot analysis
This analysis was carried out exactly as described (28).
Brieﬂy, equal volumes of culture were centrifuged, super-
natants were removed and the cell pellets stored at –808C.
Pellets were resuspended in 1  SDS buﬀer (Novagen), and
lysed by heating at 988C for 10min. Equal amounts of
protein were loaded onto a 4–12% Bis–Tris NuPAGE
Novex gradient gel (Invitrogen) and electrophoresed at
100V in 1  NuPAGE MES buﬀer (Invitrogen). Proteins
were then electroblotted to PVDF membranes and
detected by ﬂuorescence using the ECL-plus Western
Blotting Detection System (GE Health Sciences) with
1:5000 dilution of rabbit anti-C.PvuII polyclonal serum
(Strategic Biosolutions), and a 1:25000 dilution of horse-
radish peroxidase-conjugated goat anti-rabbit IgG.
Protein bands were visualized on an Omega Molecular
Imaging System (UltraLum). The prestained MW markers
used were SeeBluePlus (Invitrogen).
Efficiency of transformation assay
Eﬃciency of transformation (EOT) is deﬁned in this study
as the relative number of transformants obtained from a
given preparation of competent cells, using a given
amount of plasmid DNA. EOT is calculated from the
ratio of transformants with a test plasmid relative to
those with a control plasmid (usually pBR322). This
term is equivalent to ‘relative transformation eﬃciency’.
For plasmid transformation the standard CaCl2-heat
shock method was used (53).
Relative restriction activity assay
The restriction activity of E. coli cells carrying PvuII R-M
system and its variants was measured through the pla-
quing eﬃciency of phage  vir. The eﬃciency of plaquing
(EOP) of  vir was calculated as the ratio of plaques
formed on E. coli TOP10 containing plasmid pBR322 to
those formed on the same strain containing a plasmid with
the PvuII R-M system or its variants.
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production following M13pvuIIwt infection
M13pvuIIwt stock and infection procedures were used as
previously optimized and detailed (30). Brieﬂy, E. coli
TOP10F’ cells (Invitrogen) were grown in LB supplemen-
ted with tetracycline (to maintain the F’ episome). At
OD600nm of 0.25, E. coli cultures containing plasmids
with promoter/operator variants fused to a promotorless
cat gene were infected with M13pvuIIwt (30) at a multi-
plicity of infection (MOI) of 15. Duplicate samples were
collected for each culture over a 100min postinfection
time course. One sample was immediately used to deter-
mine culture density, while the other was pelleted and
stored at –208C until used for CAT assay. Two separate
experiments were performed on consecutive days. CAT
production was quantiﬁed colorimetrically based on a
sandwich ELISA method (CAT ELISA kit, Roche) fol-
lowing the previously described protocol (30).
M.PvuII initiator mutants
Transcriptional (operon) fusions of C-box variants to lacZ
were generated by site-directed mutagenesis (Quick
Change, Stratagene) of the WT PpvuIIC/R –lacZ fusion in
plasmid pDK435 (28). For translational fusions, a
HindIII–SpeI Klenow-ﬁlled fragment from the WT
PvuII R-M system was inserted into vector pLex3B (54)
that had been cleaved with XhoI and SmaI and Klenow
ﬁlled. This yielded pLex-met1, in which lacZ is preceded
by 26 pvuIIM codons in the same reading frame.
Individual M!L replacements were introduced by site-
directed mutagenesis. All generated mutations were
sequence conﬁrmed. LacZ assays were performed as
described in earlier section.
MTase activity assay
The M.PvuII gene was ampliﬁed by PCR (primers: ACTT
TGAATCTACAGACTATGAG and GTTGCTGCAGT
ACGAACCAA), cleaved with PstI and cloned after the
araBAD promoter of pBAD24 (cleaved with NcoI,
Klenow-ﬁlled then cleaved with PstI). The resultant
pBadMTwt was used as a template for site-directed muta-
genesis, to obtain pBadMT2 and pBadMT3 (Table S1).
To replace the plasmid’s origin of replication and antibi-
otic marker, all three derivatives were separately cleaved
with ClaI and ApaLI, then Klenow-ﬁlled, and a fragment
encompassing PBAD–pvuIIM was ligated to an NheI–
ApaLI Klenow-ﬁlled fragment from plasmid pIM4
(Table S1). This fragment contains the p15A replication
origin and a gene for kanamycin resistance, making the
plasmids compatible with the R.PvuII substrate plasmid
pUC 7PvuII. Plasmids pBadMTwt-kan and its variants
[pBadMT2-kan (N4S/S10R) and pBadMT3-kan (N4S/
M8L/S10R) (Table S1)] were introduced into E. coli
TOP10 together with high copy pUC 7PvuII plasmid
(Table S1) carrying seven PvuII sites. The dual transfor-
mants were grown in MOPS-glucose media as described
above. After 4-h induction with diﬀerent arabinose con-
centrations (from 0 to 0.2%), cells were harvested and
their plasmid DNA was isolated. XhoI enzyme was
added to linearize pBad derivatives, which have no
PvuII site. Equal amounts of DNA (400ng) digested
with 10u of PvuII restriction enzymes (NEB) were run
on 1% agarose TAE gels to compare the methylation
status of the substrate plasmid.
RESULTS
Intra-operator spacersdiffer between OL andOR
Recently sequenced bacterial genomes are revealing many
putative C protein-like open reading frames, and their
upstream C-box operator sequences. We have analyzed
the C box/promoter regions for 21 PvuII-like C proteins
(25,28,33) and found that the boxes resemble two pairs
of gapped symmetrical inverted repeats linked by a cen-
tral spacer: GACTnnnAGTC(TGTA)GACTnnnAGTC
(Figure 1). The WT PvuII C box region diﬀers from the
symmetrical pattern at just two of 16 positions:
in boxes 1A (GACT!TACT) and 2A (GACT!GATT)
(Figure 1B and C). Logo analysis (55) for C proteins
having a HRTY recognition helix revealed that the central
4-nt TGTA spacer is more highly conserved than the sym-
metry elements themselves (Figure 1C) (25,28). We found
that all four bases of the ‘inter’-operator TGTA spacer are
required for C.PvuII-dependent activation (28). The 3-nt
‘intra’-operator spacers within OL and OR (‘nnn’ above)
are also well conserved; for PvuII the actual spacers are
CAT and CAA, respectively (Figure 1B and C). These
spacers form part of an alternative symmetry among C-
boxes that was recently found in interaction of
C.Esp1396I with its C-box DNA (41).
We have found that C.PvuII has higher in vitro aﬃnity
for OL than for OR, even when the same symmetrical
C-box core sequence is used in both OL and OR
(GACTcatAGTCtgtaGACTcaaAGTC) (‘PvuSym’ in
Figure 2A) (28). This result suggested that the two 3-bp
intra-operator spacer sequences (and/or their associated
alternative symmetry) might determine the relative aﬃnity
of C.PvuII for the two operators. Logo analysis reveals
that the preferred sequence for both operator spacers is
TAT, with particularly high conservation of the A posi-
tion at the center (Figure 1C). This is consistent with the
C.Esp1396I–C-box co-crystal structure (41), but does not
explain conservation of the inverted repeats (Figure 1C).
The spacer consensus is the same for OL and OR
(Figure 1C), but an analysis of 21C-box regions from
the C.PvuII subfamily (28) reveals that only two of 21
(<10%) have the same spacer in both operators
(Figure S1). We sought to explore the roles of the intra-
operator spacers and the alternative symmetry of which
they are a part.
Altering operator spacers doesnotprevent C.PvuII tetramer
formation, and still yieldsan activation-repression in vivo
Our ﬁrst aim was to investigate the relative importance of
the two alternative symmetry elements for C.PvuII bind-
ing and C gene regulation: the AGTC C-boxes themselves
(33) (blue in Figure 2A), as well as the recently reported
intra-operator spacer-associated ‘TATA’-based symmetry
(41) (yellow in Figure 2A). We used site-directed
Nucleic AcidsResearch, 2009, Vol.37,No. 3 987mutagenesis to generate C-box intra-operator spacer var-
iants. In two cases, both operator spacers (OL/OR) were
identical: TAT/TAT (pIM57) to perfectly match the
‘TATA’ symmetry based on C.Esp1396I structure data
(41) (Figure 2A) or CGC/CGC (pIM68) to disrupt that
pattern. We also made variants in which one operator had
TAT and the other had CGC: TAT/CGC (pIM58) or
CGC/TAT (pIM67).
We ﬁrst carried out in vitro EMSA. C.PvuII formed
apparent tetramer complexes in each case, even when
the ‘TATA’ consensus was replaced in both operators by
CGCA; binding was weaker, but the low-mobility com-
plex formed (Figure 2B). Interestingly, the CGC/TAT
variant showed reduced cooperativity with an intermedi-
ate EMSA species appearing (Figure 2B). In contrast, our
previous data from variants in the C-boxes themselves (28)
(summarized in Figure 2A) revealed the absence of low-
mobility complexes when just box 2A of OR was reversed,
even though the ‘TATA’ consensus was intact [Figure 2A,
see also Figure 3B in (28)]. Together, these ﬁndings sug-
gest that the AGTC symmetry plays a substantially larger
role than the ‘TATA’ symmetry for C.PvuII in vitro
binding.
To test the eﬀects of these changes in vivo, the same
spacer sequence variants were cloned in front of lacZ.
The resulting transcriptional fusions were used to
B
C
D
A
Figure 3. Eﬀect of exchanging or duplicating the native intra-operator spacers. (A) C.PvuII titration experiment performed as in Figure 2C. Closed
symbols represent LacZ activity from PpvuIICR–lacZ fusions with, respectively, the native PvuII C-boxes with CAT/CAA intra-operator spacers
(ﬁlled diamonds, pDK435), the symmetrized C-box variant with native spacers (ﬁlled circles, pIM8), the symmetrized variant with CAA/CAA spacers
(open circles, pIM13), with CAT/CAT spacers (ﬁlled squares, pIM10) and with CAA/CAT spacers (open squares, pIM14). The nonrepressing C-box
mutant (pWWWR) was added as control (open diamonds). All cells contain a compatible plasmid carrying PBAD–pvuIIC (pIM1). As C.PvuII
negative control pBAD24 was used with pDK435 (triangles). (B) C.PvuII concentrations giving peak expression. Same data as shown in (A), but
normalized to the highest expression value (LacZ modiﬁed Miller units) for each variant. (C) Same plasmids used in (A), but with C.PvuII delivered
at a physiological level from the WT C-box/promoter in the intact R-M system (pPvuRM3.4, black bars), or elevated level from a nonrepressing
C-box mutant of R-M system (pIM6, gray bars). A plasmid with no C.PvuII gene was used as a negative control (pBR322, white bars). The symbols
at the bottom facilitate comparison to (A) and (B). (D) Arabinose-induced WT C.PvuII production visualized by western blotting. Plasmid pIM1
(also used in A) was in E. coli cells growing in the indicated arabinose concentration. The level of C.PvuII produced from pPvuRM3.4 and its
nonrepressing variant (pIM6) were also determined. The asterisk indicates the C.PvuII level at 0.02% arabinose induction, corresponding to the
highest level of PpvuIICR–lacZ transcription [peak for black diamonds in (A)].
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intracellular C.PvuII protein levels (from a PBAD arabi-
nose inducible promoter) could be varied from near 0 to
above the physiological wild-type level (28). The
TAT/TAT variant was not greatly aﬀected relatively to
WT-Sym operators, but appeared to enter the repression
phase at a slightly lower C.PvuII concentration
(Figure 2C). The radical CGC/CGC variant is poorly
expressed, but still shows signiﬁcant activation and appar-
ent onset of repression by C.PvuII. Again, in comparison,
reversal of C-box 2B resulted in complete loss of repres-
sion (next section and Figure 3A).
Altered operator spacerscan lead torepression at lower
intracellular levels ofC.PvuII
We next investigated the role of the native intra-operator
spacers (CAT in OL and CAA in OR), in the context of
fully symmetrical C-boxes. We used site-directed mutagen-
esis to generate spacer variants upstream of a promoterless
lacZ gene. In two cases, both operator spacers (OL/OR)
were identical: CAT/CAT (pIM10) or CAA/CAA
(pIM13). In the other two cases the spacers were
exchanged (CAA/CAT, pIM14), or remained as in WT
(CAT/CAA, pIM8). We also tested WT spacers in the
context of the natural nonsymmetrical C-box (pDK435)
(Table S1).
We titrated C.PvuII in these PpvuIIC/R -lacZ transcrip-
tional fusion strains using a compatible PBAD–pvuIIC
plasmid. Western blot analysis of the resulting ramp in
C.PvuII levels is shown in Figure 3D. For WT C-boxes,
as before (28), activation was seen with a peak 1.5-fold
above baseline at about 0.02% arabinose, followed by
strong repression at 0.2% arabinose to the level of the neg-
ative control (vector, no pvuIIC; Figure 3A). All tested
intra-operator spacer variants, except for the reciprocally
exchanged spacers (pIM14), showed very similar tran-
scription proﬁles, though peak heights varied. The WT
C-box fusions gave the highest maximal activation of the
tested variants. The reciprocally exchanged spacer variant
(CAA/CAT; pIM14) showed the same general proﬁle with
respect to inducer concentration, but with substantially
decreased expression (about 10-fold less at peak) than its
WT symmetrical variant at peak (pIM8).
A most striking ﬁnding was that the peak of expression
for tested spacer variants depended on the spacer sequence
in OL, but not in OR. We normalized the data shown in
Figure 3A to the highest expression for each variant, to
facilitate their comparison (Figure 3B). The two variants
with CAA in OL (regardless of the OR spacer sequence)
gave peak expression at 0.002% arabinose, in contrast
to variants with CAT in OL, for which the peak was at
0.02% arabinose. The ascending part of the expression
proﬁles at C.PvuII concentration presumably correspond
to the relative binding aﬃnity of the activating
operator OL with CAA, which may be higher than with
CAT spacer.
We next tested the levels of reporter gene transcription
fused to the various C-box spacer variants in the context
of the entire WT PvuII R-M system carried on the
pBR322 vector (9), producing the physiological C.PvuII
concentration in the cells growing exponentially at 378Ci n
MOPS-glucose media (as described in ‘Materials and
methods’ section). The WT C.PvuII level is close to that
produced in 0.008% arabinose (Figure 3A) as also shown
by western blot (Figure 3D). The expression of each vari-
ant (black bars; Figure 3C) was compared to the position
on the titration proﬁle (Figure 3A). As a negative control,
we used vector without the pvuIIC gene (white bars,
Figure 3C), and saw minimal expression due to C.PvuII-
independent promoter activity. As a positive control we
supplied the pvuIIC gene in the context of the WT R-M
system (pIM6; gray bars, Figure 3C), but with mutation of
OR C-box 2B that prevents repression [open diamonds in
Figure 3A; (28)]. C.PvuII is elevated in these cells
(Figure 3D) and we saw the expected drop in expression
for all variants except the nonrepressing fusion itself
(pIM9) (Figure 3C).
At the physiological C.PvuII level, the variants with two
CAA or two CAT spacers are indistinguishable (black
bars, Figure 3C), but the rest of the titration data indicate
that the CAT/CAT operator is still in the transcription
activation phase, while the CAA/CAA operator is under-
going repression (Figure 3A). These data suggest that the
activation/repression circuit is not greatly disturbed by the
CAT/CAA variants (Figure 3A), but just modulated.
The OL intra-operator spacer contributes more tonet
C.PvuII-binding affinity thanthe OR spacer
As noted in the previous section, the C-box region of
PvuII and similar R-M systems includes two symmetry
patterns. One (blue in Figure 2B) has two equivalent
gapped palindromes referred to as OL and OR (33).
From this information alone, one might expect the two
intra-operator spacers to have equivalent eﬀects with
respect to C.PvuII binding. We asked if the intra-operator
spacers might be involved in the determination of relative
C.PvuII aﬃnity to OL and whether the in vivo observa-
tions might be due to diﬀerential aﬃnity binding.
We tested this in two ways, via EMSA and competition
EMSA. We used 126-bp PCR products, ampliﬁed from
various plasmids, at a ﬁxed concentration of 20nM. The
26-bp C boxes were located at the center of the ampliﬁca-
tion product, ﬂanked on each side by 50bp of DNA. For
each variant we used 0–300nM C.PvuII. As with the
in vivo lacZ fusions described above, we exchanged the
two native intra-operator spacers, or made them equiva-
lent. The EMSA results for all intra-operator spacer var-
iants show the same distinct low-mobility complex
obtained for WT C-boxes [(28) and Figure S3A].
C.PvuII has substantially greater aﬃnity for the fully sym-
metrical C-box variants than for the WT C-boxes, based
on disappearance of the unshifted complex (Figures 4A
and S1A). We tested this result further via competition
EMSA, using unlabeled variant DNA fragments in 1-,
2.5-, 5- or 10-fold molar excess with a ﬁxed amount of
biotin-labeled WT C-box DNA. The results (Figures 4B
and S4B) indicate signiﬁcantly higher C.PvuII aﬃnity
for OL with a CAA spacer than with a CAT spacer.
With OL=CAA, 10-fold excess of competitor resulted
in nearly 90% loss of the shifted band; in contrast,
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only about 30% of the shifted complex. The OR spacer
appears to have a smaller eﬀect on net C.PvuII aﬃnity
than the OL spacer (Figure 4B), even though the ﬂanking
GATCnnnAGTC symmetry elements of each operator
were identical. None of these variations signiﬁcantly
altered cooperativity, as judged by Hill coeﬃcients
(Figure S5).
C.PvuII bendsDNA within C-boxes/promoter region
We next asked whether the OL spacer eﬀects might result
from structural changes in the DNA. Other C proteins
bend C box DNA, causing local distortion at both oper-
ator sites, as previously demonstrated for C.AhdI (40) and
C.EcoO109I (38). To estimate the DNA bending angle, we
cloned C-box DNA fragments into the center of the
pBend2 plasmid (51), ﬂanked by a variety of restriction
sites. Restriction cleavage yielded a set of constant length
DNA fragments, but with diﬀerent relative location of the
C-boxes. The electrophoretic mobility of DNA complexes
with C.PvuII allow estimation of average bending (52,56).
We did not expect a large net bending angle, because the
15-bp center-to-center spacing of the operators places
them on opposite faces of the DNA helix, and bends at
each operator should partially cancel one another. In fact,
for the C.Esp1396I tetramer, the overall bend angle calcu-
lated from crystal structure analysis is about 438 and
results from the two individual bends imposed by each
dimer related by 1508 rotation (41).
We compared bend angle calculated for WT C-boxes
and the symmetrical variant with CAA spacer in OL
(Figure 5). We did not ﬁnd a major diﬀerence in the mobi-
lity, with DNA being bent by 44.5 1.58 for WT and
48.0 0.58 for OL spacer=CAA. We cannot, however,
rule out the possibility that this slight diﬀerence might
be enough to aﬀect C.PvuII aﬃnity (57).
Higher affinity forOL impairs establishment and
maintenance ofthe PvuIIR-M system
When OL contained a CAA spacer, reporter gene fusions
revealed higher transcription from PpvuIICR at lower
C.PvuII concentrations, than when the WT CAT spacer
was present (Figure 3B). This result corresponds to higher
aﬃnity in vitro, as revealed by EMSA (Figure 4B). We
next determined how the change in C.PvuII aﬃnity
aﬀected the temporally controlled balance between PvuII
modiﬁcation and restriction. We used site-directed muta-
genesis to place the same operator spacer sequences as
used in Figures 3 and 4 in the context of the entire
PvuII R-M system. This yielded plasmids pIM17 (spacer
OL=O R=CAT); pIM18 (spacer OL=O R=CAA) and
pIM19 (spacer OL=CAA; OR=CAT) (Table S1). As
controls, we used the WT PvuII R-M system plasmid
(pPvuIIRM3.4; OL=CAT; OR=CAA) and its activated
but nonrepressing variant (pIM6) (28). Our previous data
(28) showed that lack of repression increases amounts of
REase relative to MTase, presumably increasing the risk
of damage to the new host’s chromosome.
To study the eﬀects of intra-operator spacers on estab-
lishment in new cells, plasmids carrying the intact R-M
system or its variants were introduced into cells and the
eﬃciency of transformation (EOT) was determined. Two
sets of competent cells were prepared: one strain carried
the pvuIIM gene (M
+; plasmid pPvuM1.9-ACYC), so the
cells were fully protected before the R-M system was
introduced, while the other strain lacked pvuIIM (M
 ;
pACYC184). The relative EOTs were expressed as the
fraction of colony-forming units (CFUs) for M
– versus
M
+, and then normalized to the values for vector control
transformations. The wild-type PvuII R-M system showed
no signiﬁcant diﬀerence in EOT from the vector control
pBR322 (Table 1). The nonrepressing plasmid (pIM6),
pIM20 (WT spacers, fully symmetrical C boxes) and
pIM17 (spacer OL=O R=CAT) showed similar about
AB
Figure 4. In vitro interaction of C.PvuII protein with wild-type and altered C-box regions. (A) EMSA reactions were processed as outlined in
‘Materials and methods’ section and shown in Supplementary Data (Figure S4). Data are shown as % of unshifted DNA versus increasing
concentration of added C.PvuII. ‘WT’ refers to the native PvuII C-boxes and spacers. The others all have symmetrized spacers with varied intra-
operator spacers. (B) EMSA competition assays were performed using 200nM of C.PvuII and 20nM of biotin-labeled WT C-box 126-mer (as
described in ‘Materials and methods’ section). Competition reactions contained increasing amounts of unlabeled 126-mer DNA fragments (from 1- to
10-fold molar excess). The competitor DNAs contained intra-operator spacers: CAA/CAA (white circles), CAA/CAT (white squares), CAT/CAA
(black squares), CAT/CAT (black circles) or no C-boxes (triangles, negative control). Following EMSA and electroblotting, the shifted bands for
each reaction were visualized and quantiﬁed via chemiluminescent detection of the biotinylated DNA as described in ‘Materials and methods’ section.
For clarity symbols are the same as in Figure 3.
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was observed for two variants having OL=CAA
(pIM18, OR=CAA; and pIM19, OR=CAT). Both
showed drastic >100-fold reductions in comparison to
WT PvuII R-M (Table 1). These plasmids appear to
have had selectively lethal eﬀects on M.PvuII
– cells, as
their transformation of M.PvuII
+ cells was eﬃcient.
We next tested whether this apparently lethal eﬀect for
OL=CAA is due to a crucial temporal perturbation in
R-M system establishment leading to premature REase
expression. Cells carrying both a C-box operator variant
plasmid and the compatible plasmid pPvuM1.9-ACYC
(M
+) were transformed with pACYC-kan (M
–). One of
the plasmids was expected to be lost during growth with-
out antibiotics to permit plasmid segregation, since
pPvuM1.9-ACYC (M
+) and pACYC-kan (M
–) belong
to the same incompatibility group (p15A) (58).
Transformants were then plated with selection for both
the R-M system plasmid and pACYC-kan (M
–). The ques-
tion was whether established R-M system variants still
required the second MTase
+ plasmid. Spacer variants
with OL=CAT, including WT and WT-Sym R-M
system variants grew well without pPvuM1.9-ACYC
(M
+) (Table 1, Figure S2). In contrast, additional
MTase activity was apparently indispensable when OL
spacer=CAA, as M
– segregants were not found. This
implies an inability of the variant R-M system to be main-
tained, even after establishment (Table 1), suggesting that
elevated (rather than, or in addition to premature) REase
expression is responsible for reduced EOT.
While we could not test variants with OL=CAA with-
out additional M+ activity present (as just described), we
tested whether the observed  30% reduction in EOT for
A
B
C
Figure 5. DNA bending by C.PvuII. WT C-boxes (A) and OL spacer variant with CAA (B). With the indicated restriction enzymes 150-nt DNA
fragments (60-ng each) were released, and contain the C-box in the center (EcoRV) or close to either end (MluI or BamHI). C.PvuII (200ng) was
added and EMSA was carried out (as in Figure 3). (C) Flexure displacement analysis was as described (52). The net DNA bending average angle was
calculated.
Table 1. The eﬀect of altered spacers in OR or OL on PvuII R-M
system establishment and maintenance
C box intraoperator
spacers OL/OR
Relative EOT
(%)
a (pvuIIM
+
pvuIIM
  host)
Ability to replace
co-existing
pPvuM1.9-ACYC
(M
+) with
pACYC177-
kan (M
 )
b
No PvuII R-M (pBR322) 100 7+
CAT/CAA, WT
(pPvuRM3.4)
98 13 +
CAT/CAA, Sym (pIM20) 30 3+
CAT/CAA, Sym (pIM6) 34 3N D
c
CAT/CAT, Sym (pIM17) 26 7N D
c
CAA/CAA, Sym (pIM18) 0.2 0.1
d  
CAA/CAT, Sym (pIM19) 0.7 0.4
d  
aEqual amounts of plasmid DNAs with PvuII R-M system and its C-box
spacer variants were used to determine the eﬃciency of transformation
(EOT) in each of two host strains. These plasmids were introduced into
competent E. coli TOP10 cells that already carried either the gene for the
PvuII MTase (pvuIIM; plasmid pPvuM1.9-ACYC) or a vector control
(pACYC177). Relative EOT was determined as the fraction of M.PvuII
–
transformants obtained relative to the number of transformants for the
M.PvuIIM
+ strain, and then normalized to the pBR322 EOT ratio. The
standard deviation is indicated.
bThe same competent cells, having indicated plasmid and pPvuM1.9-
ACYC (M
+), were transformed with pACYC-kan (M
–) and grown
without antibiotics for 2h to allow plasmid segregation. As they
belong to the same incompatibility group, either pPvuM1.9-ACYC or
pACYC-kan should be lost unless the plasmid is essential. Potential
segregants were plated with selection for R-M system plasmid
(Amp
R) and pACYC-kan (M
–) (Kan
R). Lack of transformants after
overnight incubation indicates a requirement of additional MTase
expression for R-M system maintenance.
cND, not determined.
dSmaller colonies, viability problems.
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vated restriction activity. For this purpose, we determined
the eﬃciency of  vir phage plaquing (EOP) to estimate
relative restriction. We measured restriction relative to a
nonrestricting reference strain and to the WT PvuII R-M
system. The data in Table 2 show comparable relative
restriction for cells with WT (pPvuRM3.4) or WT-Sym
(pIM20) PvuII R-M systems, despite their 3-fold diﬀer-
ence in EOT values (Table 2). Similarly, EOT values for
WT-Sym (pIM20) and its nonrepressing variant of
OR (pIM6) were very close, despite relative restriction
being more than 5-fold higher for the nonrepressing var-
iant. In vivo restriction is a complex process, and its rela-
tionship to the number of target restriction sites and the
relative amounts of REase and MTase have not been
shown to have a predictable linear nature. However,
the fact that restriction by the poorly established variants
on plasmids pIM17 and pIM20 is marginally less than in
the WT PvuII R-M system (Figure S3) does not support
the model that their reduced establishment is due to
increased restriction.
Effects of OL spacer on kinetics ofC.PvuII-activated in vivo
geneexpression
The drastically decreased eﬃciency of transformation for
C-box variants having a CAA spacer in OL might be due
(in part) to a disturbed temporal control of R-M genes by
activation at lower C.PvuII concentration, with premature
REase expression, in comparison to OL=CAT.
We ﬁrst determined whether the kinetics of C protein
activation (30) diﬀers when the OL spacer is CAA versus
CAT. We placed C box variants in front of a promotorless
cat (chloramphenicol acetyltransferase) reporter gene.
CAT production can be easily measured by a sensitive
colorimetric assay based on ELISA sandwich method
(see ‘Materials and methods’ section). The pvuIIC gene
was introduced into these cells via the WT PvuII R-M
system present on M13 bacteriophage (Figure 6A), in a
fairly synchronized manner (30). We used three spacer
variants tested previously by in vivo C.PvuII titration
(Figure 3), all in the context of symmetrized C-boxes:
WT (CAT/CAA; pDK178), CAA/CAA (pIM22) and
nonrepressing (box 2B reversed, pWWWR) as a control.
The ﬁrst two variants have identical, symmetrical
GACTnnnAGTC cores and diﬀer only by a single nt in
the intra-operator OR spacer. A control plasmid without
C-box sequence (pKK232-8) was also tested. Host cell
cultures showed comparable growth (Figure 6B). The cul-
tures were infected with recombinant M13pvuIIwt at an
MOI of 15 in duplicate. Postinfection CAT production
was measured at diﬀerent times up to 100min
(Figures 6C and S6).
Cells infected with M13pvuII carried WT C-box oper-
ator spacers (CAT/CAA, symmetrical or nonrepressing
variant) showed similar exponential normalized CAT pro-
duction rate until about 50min postinfection, after which
the nonrepressing variant produced CAT at a higher rate
(Figure 6C). In contrast, in the OL=CAA variant, CAT
production rose until about 50min postinfection, more
rapidly than OL=CAT, but subsequent accumulation
slowed, eventually yielding the lowest levels among
tested variants (Figure 6C). The diﬀerent activation proﬁle
for OL=CAA thus appears to be associated, at least in
part with temporal misregulation.
Translation initiation of pvuIIM isnot affected by tested
pvuIIC C-boxoperator variants
A second possible explanation for the strong eﬀects of
OL=CAA spacer variants is that the coding sequence
of MTase gene on the opposite strand is also changed.
PvuII MTase has four ATG codons near its N terminus
(Figure 7), so we began by determining the start of trans-
lation. The puriﬁed, overexpressed and active M.PvuII is
made in two forms (38.3 and 36.9kDa) due to alternative
translation initiators that would correspond to diﬀerence
in size about 13 amino acids beginning at the ﬁrst and
fourth methionines [(3,22); Figure 7]. The M.PvuII shorter
form is about 20-fold more abundant than the larger form
(9). The spacer in OL=CAT (WT) overlaps the third
methionine codon (59), and mutation to CAA generates
a Met!Leu MTase change (UUG on MTase strand;
Figure 7).
We generated translational fusions in which lacZ fol-
lowed 26 PvuII MTase codons. Variants with AUG (M)
sites replaced by UUG (L) were generated to estimate the
contribution of each methionine codon as a translation
initiation start. Our data indicate that the second AUG
is indispensable for translation (Figure 7). The M!L
change opposite the OL spacer did not detectibly aﬀect
pvuIIM translation.
Effect of M!Lsubstitution on M.PvuII MTaseactivity
We next tested whether PvuII MTase kinetics or activity is
changed by the M!L substitution at the third methio-
nine, opposite the OL spacer. WT pvuIIM and its variants
were cloned downstream of the PBAD promoter, so its
expression is modulated by arabinose. The cells also con-
tained a second plasmid bearing seven PvuII sites. A rise
in MTase expression would result in greater number of
methylated PvuII sites within the second plasmid, detec-
tible by digestion with cognate PvuII REase. For these
experiments we also tested M.PvuII substitution
Table 2. Relative restriction activity of C-box spacer variants estimated
from eﬃciency of plaquing (EOP) of  vir phage
C box spacer (plasmid name)
OL/OR
PFU
a Restriction
b
relative
to R
 M
 
Restriction
c
relative to
WT R
+M
+
no PvuII R-M (pBR322) (3.2 0.8) 10
9 1–
CAT/CAA, WT
(pPvuRM3.4)
(8.8 0.2) 10
3 3.6 10
5 1.00
CAT/CAA, Sym (pIM20) (1.0 0.2) 10
4 3.1 10
5 0.86
CAT/CAA, Sym
d (pIM6) (2.0 1.0) 10
3 1.6 10
6 4.40
CAT/CAT, Sym (pIM17) (7.4 1.1) 10
4 4.3 10
4 0.12
aPFU (plaque-forming units).
bCalculated as PFU obtained for control, nonrestricting strain [E. coli
TOP10 (pBR322)] divided by PFU obtained for tested strain.
cNormalized to PFU for WT R-M system.
dNonrepressing mutant.
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mids with M.PvuII variants, were: pBadMT2 (N4S/
S10R, symmetrized C-box) and pBadMT3 (N4S/M8L/
S10R, symmetrized and with CAA sequence in OL
spacer). The degree of DNA protection under the same
conditions of increasing MTase expression levels was com-
pared for the three variants (Figure 8). The DNA was
clearly protected by lower levels of WT M.PvuII than
for the two other MTase variants (compare lane 7 for
each MTase, Figure 8). However, the somewhat lower
B
A
C
Figure 6. In vivo eﬀects of C-box OL spacer variants on temporal expression of C.PvuII. (A) Diagram of experiment. Four E. coli TOP10’ cultures
carrying plasmids with diﬀerent OL spacers fused to a cat (chloramphenicol acetyltransferase) promotorless reporter gene were infected with
recombinant M13pvuIIwt phage at MOI=15. We used three spacer variants tested previously in this study: WT-Sym (CAT/CAA; pDK178;
closed circles), CAA/CAA (pIM22; open circles) and nonrepressing WT-Sym (box 2B mutated, pWWWR; gray circles) as a control. The ﬁrst
two variants have identical, symmetrized C-boxes sequences, and diﬀer only at a single nt in OR. A plasmid with no C-box sequence (pKK-238;
triangles) was also tested and gave only background levels of cat expression (shown in Figure S6). (B) Growth was monitored at OD600nm before and
after phage addition. (C) CAT production over infection time for two independently performed experiments was measured by sensitive colorimetric
assay based on ELISA sandwich method (see ‘Materials and methods’ section). CAT production data were normalized to the value for each strain
prior to infection. Curves were ﬁtted and statistical analysis was performed using the SAS package (SAS Institute Inc., Cary, NC). The analysis of
covariance indicated signiﬁcant diﬀerence of slopes over time with P<0.0001. Individual slopes for variants in pairs were also compared having:
P=0.0057 (pDK178 versus pIM22), P=0.0001 (pDK178 versus pWWWR) and P=0.0001 (pIM22 versus pWWWR).
Figure 7. Mapping translational start for pvuIIM. Overlapping C-box sequences of pvuIIC and pvuIIM N-terminus in complementary strands shown
at top. RBS, ribosome binding site. The E. coli RBS Logo (62) is aligned to M2 as initiator. The methionine residues are marked in bold. Presence of
4 WT methionine codons was designated as MMMM. Mutation of the ﬁrst M codon to L is listed as LMMM; and so on. Each of the variants was
translationally fused to lacZ. For all mutants, translation activity was measured as modiﬁed Miller units of LacZ as described in ‘Materials and
methods’ section.
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C-boxes (Table 1) might be associated with reduced pro-
tection by M.PvuII (N4S/S10R). No diﬀerence in protec-
tion is obvious between variants N4S/S10R and N4S/
M8L/S10R. This result suggests that the OL spacer
change has no detectible eﬀect on MTase activity in the
context of the symmetrized C-box sequence.
DISCUSSION
WhatdoesC.PvuII recognize?
C-boxes are binding sites that are believed to be recog-
nized by the HTH motifs of C proteins from R-M systems.
C-boxes of the PvuII family (28) have two
GACT(N3)AGTC (consensus) palindromes, separated by
a 4-bp inter-operator spacer (Figure 1C). The consensus is
recognized with high cooperativity by C.PvuII (28) and
C.AhdI (29,42). C.PvuII has greater binding aﬃnity
for the symmetrical C-box consensus than to the WT
C-boxes (Figure 3A), as also seen with symmetrical
consensus operators for lac repressor (60) and phage  
Cro repressor (61).
A recent co-crystal structure of C.Esp1396I with its
C-box DNA (41) suggested recognition of an alternative
symmetry element within the C-box region (Figure 2A).
Both symmetries, abbreviated ‘AGTC’ and ‘TATA’ (the
latter spanning the intra-operator sequence), are well con-
served in C.PvuII family C-boxes, though with slightly less
conservation of the ‘TATA’ match within OR than within
OL (Figure 1C). The C.Esp1396I structure reveals a center
of symmetry shifted by 0.5nt relative to the ‘AGTC’
consensus, with the center of the ‘TATA’ pattern at the
‘T’ of the CGTG central spacer (41). The ‘TATA’ recog-
nition seems to involve indirect readout, with speciﬁc con-
tacts limited to the C-box ﬂanks (conserved TG/CA at
outer edges in Figure 1C) and within the inter-operator
spacer (41).
This result is surprising given our previous in vitro bind-
ing studies of C.PvuII, that showed mutations within the
‘AGTC’ symmetry led to loss of tetramer complex at
any tested protein concentration, even though the
‘TATA’ symmetry was unchanged (Figure 2A, WWWR)
(28). Similar data were obtained for C.AhdI (like
C.Esp1396I a member of the DRTY subfamily), where
changes in box 1A of OL and 2B of OR led to complete
loss of binding, despite the ‘TATA’ symmetry being undis-
turbed (42).
To assess the role of the ‘TATA’ symmetry, we stud-
ied the impacts of C-box variants on C.PvuII with
TATA!CGCA mutations in both OL and OR.
Tetramer complexes still formed in vitro, though only at
higher concentrations of C.PvuII (Figure 2B). More
importantly, in vivo assays showed that transcriptional
activation and repression still occurred (Figure 2C),
though at lower peak expression levels than in the
WT-Sym C.PvuII variant. Collectively, this evidence sug-
gests that the ‘AGTC’ consensus is more important than
the ‘TATA’ symmetry for binding, at least for C.PvuII.
The C.Esp1396I structure may not be fully representa-
tive, in that the C box is very unusual in having identical
intra-operator spacers in OR and OL that both perfectly
match the ‘TATA’ symmetrical consensus (there are also
two hypothetical systems in the PvuII family with this
Figure 8. Methylation status of plasmid isolated from cells expressing varied levels of WT M.PvuII or its variants. The complementary strands for
the symmetrized C-box region of the PvuII R-M system are shown at the top. The upper strand speciﬁes M.PvuII. The two changes that symmetrize
the C-boxes are shown in red, along with the resultant changes in the MTase sequence (N4S/S10R). Substitution of the OL spacer, from CAT to
CAA, would result in an additional change (M8L). Escherichia coli TOP10 cells carried two plasmids: pUC 7PvuII (with seven PvuII sites) and
plasmids expressing either WT pvuIIM (pBadMTwt-kan) or one of its variants (MTase N4S/S10R–pBadMT2-kan; MTase N4S/S10R/M8L–
pBadMT2-kan) under the arabinose inducible promoter PBAD. After induction with a range of arabinose concentrations, cells were pelleted and
plasmid DNA was isolated. The extent of methylation was assessed by digestion with PvuII restriction enzyme. Results ranged from full cleavage (no
protection as in control lane 1; asterisk shows the position of highest bands) to no cleavage (complete methylation as in control lane 2). Digests were
resolved on 1% agarose gel. Lanes 4 to 8 for each MTase represent equivalent increasing arabinose concentration from 0.01 to 0.2%. The topmost
band in lanes 4–8 for each MTase is the pBAD plasmid linearized with XhoI prior to digestion with PvuII indicated by arrow; pUC 7PvuII lacks a
XhoI site. M lane shows DNA markers (1kB Plus ladder; Invitrogen).
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HTH recognition helix in the C.Esp1396I structure makes
no DNA contacts. It will be interesting to see if co-crystal
structures for C-boxes lacking this perfect ‘TATA’ match
show the same positioning. While C.PvuII and
C.Esp1396I may simply diﬀer in their DNA recognition,
it is also possible that the tetrameric repression complex
solved in (41) has substantially diﬀerent DNA–protein
interactions than a single dimer bound to OL, with the
latter perhaps relying on HTH amino acid contacts to
the ‘AGCT’ consensus.
Complexity of theC.PvuII C-boxregion
In the PvuII R-M system, several regulatory elements
overlap one another (Figure 1A and B). The PvuII C-
boxes are located amid two overlapping promoters for
pvuIICR transcription: a weak C-independent promoter,
and a strong C-activated promoter. The pvuIIM and
pvuIICR promoters do not overlap one another, and
C.PvuII has little if any eﬀect on pvuIIM transcription
(30). In addition, the translation initiation area for
pvuIIM is on the opposite strand (arrows in Figure 1A)
(25,37), with the codons for the MTase N-terminus over-
lapping the C.PvuII-binding region. Generating symmet-
rical consensus C-boxes resulted in two single-aa changes
to the MTase.
We found no eﬀect of our C-box alterations on MTase
translation initiation (Figure 7). Coupled in vitro tran-
scription-translation previously indicated that M.PvuII is
made in two forms, corresponding to translation starts
from the ﬁrst and fourth AUG, and that the shorter
form is about 20-fold more abundant than the larger
form (9). Interestingly, substitution of the fourth AUG
codon reduced translation by half using lacZ translational
fusions. The second Met codon was absolutely required
for pvuIIM translation initiation. The translation initia-
tion region of pvuIIM has very limited similarity to canon-
ical ribosome binding sites (62), regardless of which
translation initiator is analyzed (Figure 7). However the
initiating ATG codon is followed by an AC sequence that
can strongly enhance translation (63). Importantly, the
third Met codon (changed in OL intra-operator spacer
mutants) is not at all involved in translation initiation
(Figure 7).
MTase activity was tested by in vivo titration, which
revealed slightly reduced activity for the variant having
two substitutions (N4S/S10R; due to the symmetrized
C-box) (Figure 8). This may contribute to less-eﬃcient
establishment of relevant PvuII R-M system variants
(Table 1).
Interestingly, these results suggest that, if both pvuIIM
initiators are in fact used, the longer form of the MTase
plays an important role in PvuII R-M system establish-
ment (EOT for all symmetrized variants decreased to
30%, Table 1), but not necessarily in maintenance
(pIM20, Table 2). Furthermore, clones producing only
the shorter form of M.PvuII are unstable (3). During
R-M system introduction into a new host cell, MTase is
expressed ﬁrst, and endonuclease expression rises after a
delay [about 8min for PvuII, (30)]. One possibility is that
the longer MTase form is produced ﬁrst and provides
greater initial protection activity, while later the shorter,
more abundant MTase form acts as a maintenance
MTase. This possibility deserves to be tested.
Higherrelative affinity of C.PvuII forOL
Even when the operator sequences themselves
(GACTnnnAGTC) ‘and’ their spacers are identical,
there is still preferential C.PvuII binding to OL
(Figures 3C and 4B). We used in vivo assays with four
variants having identical copies of the two intra-operator
spacers. The four spacer variants were TAT or CGC
(Figure 2C) and CAT or CAA (Figure 3A). Normally,
the level of pvuIICR transcription rises with the C.PvuII
level due to autogenous activation, but repression results
at higher levels of C.PvuII (28). All four variants having
identical spacers retained transcription proﬁles showing
activation and subsequent repression, indicating forma-
tion of an OL complex prior to formation of the tetrameric
OL–OR repression complex (Figure 2A). What explains
this OL preference?
It has been proposed that competition with RNA poly-
merase reduces binding of C proteins to OR (29). While
that may be a contributing factor in vivo, it cannot explain
the OL dominance in the determination of net aﬃnity that
we observe in vitro (in the absence of RNAP) (Figure 4B).
By inference, we might predict that ﬂanking sequences
and/or the central inter-operator sequence have an
impact on C-protein regulation. There is weak conserva-
tion in the ﬂanking sequences, except for the presence of
TG/CA at the edges (Figure 1C). The C.Esp1396I tetra-
mer co-crystal structure clearly shows direct interaction of
conserved Arg35 from the recognition helix (
H/DRTY) of
subunit A with the thymine base in TG, and an equivalent
contact of subunit D with the symmetry-related TG on the
opposite strand (41). However, this interaction appears to
be symmetrical and it is not clear how it could explain the
OL preference.
The central 4nt (TGTA in the C.PvuII C-box) is
the only clearly nonsymmetrical element. In the
C.Esp1396I structure, there is a second-position contact
to the inter-operator spacer in its C-box (CGTG), from
the C protein Arg35 of subunit B. No equivalent contact is
made on the opposite DNA face via subunit C (41).
Again, however, this structure is of the tetrameric repres-
sion complex, and may not reﬂect the structure of the
initial dimer–OL complex. The basis for OL preference
remains unclear.
Modulatory role of theintra-operator spacers
The intra-operator spacers cannot by themselves explain
the OL preference, but they may contribute to it. The
analysis of 21C-box regions from the C.PvuII subfamily
(28) reveals that <10% of them have the same spacer
sequence within both operators (Figure S1). We investi-
gated the role of the spacers naturally occurring in the
PvuII C-boxes: CAT in OL and CAA in OR, in the fully
symmetrical C-box sequence context. We ﬁnd that a single
third position change in the OL spacer (CAT!CAA)
Nucleic AcidsResearch, 2009, Vol.37,No. 3 995results in a  30% rise in net C.PvuII aﬃnity, regardless of
the OR spacer sequence (Figure 4B).
Uncontacted DNA bases can still aﬀect protein aﬃnity.
For example, operators OR1 and OR3 for repressor 434
diﬀer by 3nt, where two of them are within an uncon-
tacted spacer yet substantially aﬀect relative repressor
aﬃnity (64). Detailed studies of 434 and P22 c2 repressors
reveal that uncontacted bases at the center of binding
sites are overwound, and the minor groove is substan-
tially compressed (65–67). The TAT intra-operator
spacers of C.Esp1396I are also associated with a much-
narrowed minor groove (41). Compressibility of the 434
operator minor groove depends on the absence of purine
N2-NH2 groups (68). This might explain the rarity of
guanosine in naturally occurring intra-operator spacers
of C boxes [Figure 1C, (28)] and much weaker binding
of C.PvuII to the variant CGC intra-operator spacers
(Figure 2B).
The balance of operator aﬃnities appears to aﬀect tem-
poral control of the R-M system. We observed viability
problems for cells carrying a plasmid with CAA in OL,a s
indicated by strongly reduced plasmid transformability
(Table 1). We propose that this defect results from altered
C.PvuII binding to its C-boxes and premature REase
expression. Temporal control is critical during R-M
system establishment in a new host cell (30). We tested
establishment of WT (OL spacer=CAT) and its variant
(OL spacer=CAA) in new host cells (Figure 6). C protein
appears to prematurely activate expression of a reporter
gene downstream of the CAA OL variant relative to WT
DNA. In a full R-M system, this could have lethal eﬀects
on the host cell.
Sensitivity to changes in spacer sequences may be a
powerful evolutionary tool for ﬁne-tuning regulatory cir-
cuits, because it expands the ‘tunable’ sequence beyond
just directly contacted sites. Further, the eﬀects of
sequence changes can be transmitted over 20bp through
a DNA-mediated allosteric ‘domino eﬀect’ (69). The 434
phage repressor, which governs the lysogeny versus lysis
decision, is sensitive to nucleotide variation in noncon-
tacted spacers in its three operators. This repressor and
others appear to detect DNA elastic potentials, so as to
distinguish among operators without altering speciﬁc con-
tacts (64,70–72). For mobile, temporally regulated R-M
systems, natural variation in such ﬁne-tuning might be
especially important for adaptation to a particular host’s
requirements, in controlling the potentially lethal endonu-
clease during R-M system establishment.
NOTE ADDED IN PROOF
After this manuscript was accepted, Sorokin et al.
reported a detailed analysis of C boxes (73). Their study
complements this one; the symmetry shown in Figure 1B
corresponds to their ‘‘Motif 2’’.
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